US Stock MarketDetailed Quotes

DCPH Deciphera Pharmaceuticals

Watchlist
  • 14.650
  • +0.470+3.31%
Close Apr 26 16:00 ET
  • 14.650
  • 0.0000.00%
Post 16:20 ET
1.20BMarket Cap-6397P/E (TTM)

About Deciphera Pharmaceuticals Company

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.

Company Profile

SymbolDCPH
Company NameDeciphera Pharmaceuticals
Listing DateSep 28, 2017
Issue Price17.00
Founded2003
CEOMr. Steven L. Hoerter
MarketNASDAQ
Employees355
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Smith Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-209-6400
Websitehttp://www.deciphera.com

Company Executives

  • Name
  • Position
  • Salary
  • Steven L. Hoerter
  • Director, President and Chief Executive Officer
  • 6.01M
  • Dr. Matthew L. Sherman, M.D.
  • Executive Vice President and Chief Medical Officer
  • 2.13M
  • Daniel C. Martin
  • Senior Vice President and Chief Commercial Officer
  • 1.58M
  • Thomas P. Kelly
  • Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
  • 2.03M
  • Dashyant Dhanak
  • Executive Vice President and Chief Scientific Officer
  • --
  • Jama Pitman
  • Senior Vice President, Regulatory, Quality and Portfolio Management
  • --
  • Ron Squarer
  • Chairman of the Board
  • 403.30K
  • John R. Martin
  • Independent Director
  • 388.59K
  • Frank S. Friedman
  • Independent Director
  • 382.30K
  • Patricia L. Allen
  • Independent Director
  • 398.55K
  • Dennis L. Walsh
  • Independent Director
  • 386.05K
  • Dr. James A. Bristol, PhD
  • Independent Director
  • 414.77K
  • Dr. Edward J. Benz, Jr,M.D.
  • Independent Director
  • 396.09K
  • Dr. Susan L. Kelley, M.D.
  • Independent Director
  • 396.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg